Cabergoline

CAS 81409-90-7 10 FDA-DMF suppliersSmall Molecule

Overview

Cabergoline is a long-acting dopamine receptor agonist used primarily in the treatment of disorders associated with hyperprolactinemia, including prolactin-secreting adenomas. It has been found effective in reducing prolactin levels and tumor size.

API suppliers (8)

Suppliers of Cabergoline backed by a verifiable FDA Type II Drug Master File. Source: FDA quarterly DMF list.

  • TAPI NL BV1 active DMF
  • TAPI NL BV1 active DMF
  • TAPI NL BV1 active DMF
  • IVAX CR
  • Pfizer LimitedIndia
  • APOTEX PHARMACHEM INC
  • Gedeon RichterHungary
  • MYLAN LABORATORIES LTD

Therapeutic areas

EndocrinologyNeurologyGynecology

Related APIs

Leuprolide Acetate
17 suppliers
Tamoxifen Citrate
13 suppliers
Oxytocin
13 suppliers
Bromocriptine Mesylate
9 suppliers
Sitagliptin
50 suppliers
Aripiprazole
45 suppliers
Empagliflozin
42 suppliers
Pregabalin
40 suppliers

Ready to Accelerate Your
Discovery Workflow?

Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.

Start free trialBook a demo